ATYR
Price
$0.95
Change
-$0.05 (-5.00%)
Updated
Oct 9 closing price
Capitalization
97.99M
27 days until earnings call
GNLX
Price
$5.67
Change
+$0.92 (+19.37%)
Updated
Oct 9 closing price
Capitalization
179.42M
33 days until earnings call
Interact to see
Advertisement

ATYR vs GNLX

Header iconATYR vs GNLX Comparison
Open Charts ATYR vs GNLXBanner chart's image
aTyr Pharma
Price$0.95
Change-$0.05 (-5.00%)
Volume$10.28M
Capitalization97.99M
Genelux
Price$5.67
Change+$0.92 (+19.37%)
Volume$369.03K
Capitalization179.42M
ATYR vs GNLX Comparison Chart in %
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATYR vs. GNLX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a StrongBuy and GNLX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 10, 2025
Stock price -- (ATYR: $0.95 vs. GNLX: $5.67)
Brand notoriety: ATYR and GNLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 61% vs. GNLX: 282%
Market capitalization -- ATYR: $97.99M vs. GNLX: $179.42M
ATYR [@Biotechnology] is valued at $97.99M. GNLX’s [@Biotechnology] market capitalization is $179.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green whileGNLX’s FA Score has 0 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • GNLX’s FA Score: 0 green, 5 red.
According to our system of comparison, GNLX is a better buy in the long-term than ATYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 6 TA indicator(s) are bullish while GNLX’s TA Score has 5 bullish TA indicator(s).

  • ATYR’s TA Score: 6 bullish, 5 bearish.
  • GNLX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ATYR and GNLX are a good buy in the short-term.

Price Growth

ATYR (@Biotechnology) experienced а +34.24% price change this week, while GNLX (@Biotechnology) price change was +29.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.88%. For the same industry, the average monthly price growth was +22.21%, and the average quarterly price growth was +89.30%.

Reported Earning Dates

ATYR is expected to report earnings on Nov 06, 2025.

GNLX is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+8.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNLX($179M) has a higher market cap than ATYR($98M). GNLX YTD gains are higher at: 140.254 vs. ATYR (-73.674). GNLX has higher annual earnings (EBITDA): -29.74M vs. ATYR (-68.89M). ATYR has more cash in the bank: 80.3M vs. GNLX (28M). GNLX has less debt than ATYR: GNLX (1.71M) vs ATYR (12.7M). ATYR (0) and GNLX (0) have equivalent revenues.
ATYRGNLXATYR / GNLX
Capitalization98M179M55%
EBITDA-68.89M-29.74M232%
Gain YTD-73.674140.254-53%
P/E RatioN/AN/A-
Revenue00-
Total Cash80.3M28M287%
Total Debt12.7M1.71M744%
FUNDAMENTALS RATINGS
ATYR: Fundamental Ratings
ATYR
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
99
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATYRGNLX
RSI
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 1 day ago
90%
Declines
ODDS (%)
Bearish Trend 9 days ago
83%
Bearish Trend 14 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KWTEF15.990.18
+1.14%
KIWETINOHK ENERGY CORP
AMBBY16.78N/A
N/A
Ambu A/S
TTNN0.04N/A
N/A
TITAN NRG
EQTRF0.23N/A
-2.07%
Altamira Gold Corp
MGDDY17.08-0.66
-3.72%
CIE GENERALE DES ETABLISSEMENTS MICHELIN SA CLERMONT-FERRAND

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with AMLX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
-4.70%
AMLX - ATYR
39%
Loosely correlated
+7.34%
IDYA - ATYR
39%
Loosely correlated
-0.19%
SLDB - ATYR
39%
Loosely correlated
+1.43%
NTLA - ATYR
38%
Loosely correlated
+4.05%
CRNX - ATYR
37%
Loosely correlated
+2.99%
More